Fig.2From: Hyperprogressive disease after radiotherapy combined with anti-PD-1 therapy in renal cell carcinoma: a case report and review of the literatureChest CT scan performed before administration of the first dose of nivolumab (a), during radiotherapy (b), after radiotherapy (c), after administration of the third dose of nivolumab (d)Back to article page